Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
0(0%)
Results Posted
25%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
3
20%
Ph phase_4
1
7%
Ph phase_3
3
20%
Ph phase_1
4
27%
Ph phase_2
3
20%
Ph early_phase_1
1
7%

Phase Distribution

5

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
1(6.7%)
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 3Large-scale testing
3(20.0%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
3(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(12)
Terminated(3)

Detailed Status

Completed12
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.7%)
Phase 14 (26.7%)
Phase 23 (20.0%)
Phase 33 (20.0%)
Phase 41 (6.7%)
N/A3 (20.0%)

Trials by Status

completed1280%
withdrawn213%
terminated17%

Recent Activity

0 active trials
Showing 5 of 15
completedphase_3

The Efficacy of Steroid Therapy in Vestibular Neuritis

NCT02098330
terminatedphase_1

Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)

NCT00070954
withdrawnnot_applicable

ROTEM and Dietary Supplements

NCT03125551
completednot_applicable

Cognitive and Blood Flow Effects of Mountain Tea

NCT03475823
withdrawnnot_applicable

Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

NCT01663467
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT02098330Phase 3

The Efficacy of Steroid Therapy in Vestibular Neuritis

Completed
NCT00070954Phase 1

Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)

Terminated
NCT03125551Not Applicable

ROTEM and Dietary Supplements

Withdrawn
NCT03475823Not Applicable

Cognitive and Blood Flow Effects of Mountain Tea

Completed
NCT01663467Not Applicable

Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

Withdrawn
NCT00046891Phase 3

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

Completed
NCT01046292Phase 4

Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

Completed
NCT02386852Early Phase 1

Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity

Completed
NCT02376114Phase 2

Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma

Completed
NCT00841321Phase 2

Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis

Completed
NCT00010803Phase 3

Ginkgo Biloba Prevention Trial in Older Individuals

Completed
NCT00907062Phase 1

Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents

Completed
NCT00011063Phase 1

Effect of Ginkgo Biloba on Phenytoin Elimination

Completed
NCT00034021Phase 2

Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction

Completed
NCT00010842Phase 1

Natural Antioxidants in the Treatment of Multiple Sclerosis

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15